Short Interest in Agilon Health, Inc. (NYSE:AGL) Grows By 20.5%

Agilon Health, Inc. (NYSE:AGL) saw a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 24,591,484 shares, a growth of 20.5% from the February 12th total of 20,413,986 shares. Approximately 6.1% of the company’s stock are short sold. Based on an average daily trading volume, of 7,495,718 shares, the days-to-cover ratio is presently 3.3 days. Based on an average daily trading volume, of 7,495,718 shares, the days-to-cover ratio is presently 3.3 days. Approximately 6.1% of the company’s stock are short sold.

Agilon Health Stock Down 0.2%

AGL stock traded down $0.00 during midday trading on Monday, hitting $0.60. The company’s stock had a trading volume of 1,666,035 shares, compared to its average volume of 5,845,303. The company’s fifty day moving average price is $0.69 and its 200 day moving average price is $0.80. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. Agilon Health has a twelve month low of $0.34 and a twelve month high of $6.08. The stock has a market capitalization of $248.51 million, a P/E ratio of -0.63 and a beta of 0.11.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Wednesday, February 25th. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.19). The company had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.46 billion. Agilon Health had a negative net margin of 6.60% and a negative return on equity of 120.82%. As a group, equities research analysts predict that Agilon Health will post -0.59 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Wells Fargo & Company increased their price objective on shares of Agilon Health from $1.00 to $1.50 and gave the stock an “overweight” rating in a research report on Friday, February 27th. Royal Bank Of Canada raised shares of Agilon Health from a “hold” rating to a “moderate buy” rating in a research note on Wednesday, December 3rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Agilon Health in a research note on Wednesday, January 21st. BTIG Research restated a “neutral” rating on shares of Agilon Health in a report on Friday, December 12th. Finally, Barclays reduced their price objective on Agilon Health from $1.00 to $0.50 and set an “underweight” rating for the company in a research report on Friday, February 27th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $2.18.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Agilon Health by 3.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after purchasing an additional 7,209 shares in the last quarter. Dynamic Technology Lab Private Ltd grew its stake in shares of Agilon Health by 28.4% in the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after buying an additional 10,424 shares in the last quarter. Apollon Wealth Management LLC grew its stake in shares of Agilon Health by 17.4% in the fourth quarter. Apollon Wealth Management LLC now owns 82,348 shares of the company’s stock valued at $57,000 after buying an additional 12,193 shares in the last quarter. Arrowpoint Investment Partners Singapore Pte. Ltd. acquired a new position in Agilon Health during the second quarter worth $31,000. Finally, Legal & General Group Plc increased its holdings in Agilon Health by 4.1% during the second quarter. Legal & General Group Plc now owns 346,031 shares of the company’s stock worth $796,000 after buying an additional 13,700 shares during the last quarter.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.